Introduction
============

Acute and chronic alcohol intake result in desirable and undesirable health effects.[@ehx156-B1] Modest recreational alcohol consumption may lead to perceived wellbeing,[@ehx156-B2] beyond moderate intake confers the risk of adverse outcomes. Common symptoms of acute alcohol consumption are disorientation, disinhibition, nausea, and vomiting.[@ehx156-B3]^,^[@ehx156-B4] Excessive acute abuse may lead to death.[@ehx156-B5] Chronic consumption has been ascribed cardio-protective effects.[@ehx156-B6] More commonly, chronic alcohol use dose-dependently is associated with detrimental effects including substance addiction and severe nutritional, hepatic, neurological and social consequences.[@ehx156-B7]

From a cardiovascular perspective, acute excessive alcohol consumption has been associated with the so called 'Holiday Heart Syndrome'.[@ehx156-B8] This syndrome affects individuals without a specific cardiac history resulting in both ventricular and supraventricular arrhythmias, predominantly atrial fibrillation.[@ehx156-B8]^,^[@ehx156-B9] Small case series confirmed a relation between alcohol use and atrial fibrillation.[@ehx156-B10]^,^[@ehx156-B11] Regarding chronic alcohol consumption, population-based studies reported a dose-response effect on the development of atrial fibrillation.[@ehx156-B12]

Many open questions remain. All reports on effects of acute alcohol intake were derived from small retrospective analyses with relations to arrhythmias as secondary findings. In our study, we thus intended to conduct a large, sufficiently powered, observational, cross-sectional analysis of cardiac arrhythmia prevalence in participants with quantitatively measured acute alcohol intake. Investigating visitors of the 2015 Munich Octoberfest, we hypothesized that increased breath alcohol concentration (BAC) is associated with a higher burden of cardiac arrhythmias. To parallel acute with chronic alcohol use, we studied participants of the community-based KORA Study.

Methods
=======

Study cohorts
-------------

For the analysis of BAC and arrhythmia prevalence, we designed an observational, cross-sectional cohort study and recruited voluntary visitors at the annual Octoberfest in Munich, Germany between September and October 2015 (acute alcohol cohort). Participants had to be ≥18 years of age and provide written informed consent to study inclusion. We screened and consented 3042 individuals. After exclusion of individuals with a BAC ≥3.00 g/kg (*n* = 4) and individuals with uninterpretable electrocardiogram (ECG) recordings (*n* = 8), the final study cohort comprised 3028 participants. Individuals with a BAC ≥ 3.00 g/kg are considered disabled due to intoxication according to German law, and must not be consented. The ethics committee at the Ludwig Maximilians University of Munich, Germany approved the study, which was registered at clinicaltrials.org (NCT02550340).

To assess chronic alcohol consumption on arrhythmia prevalence, we investigated participants of the Survey S4 of the community-based Co-operative Health Research in the region of Augsburg Study (KORA S4, chronic alcohol cohort).[@ehx156-B13] Study participants were identified through the registration office. Ten strata of equal size according to sex and age comprised 4261 individuals; after exclusion of those without (*n* = 95) or with uninterpretable (*n* = 17) ECGs, or without information on alcohol consumption (*n* = 18), the final cohort consisted of 4131 individuals. The ethics committee of the Bavarian Medical Association approved the study.

Electrocardiogram recordings
----------------------------

In the acute alcohol cohort, 30 s ECG recordings were obtained using the smart phone based AliveCor device (AliveCor, San Francisco, CA, USA). A two-electrode hardware extension wirelessly communicating with a software application was held with both hands by the participant, resembling a lead I ECG.

In KORA S4, digital 10 s 12-lead ECGs were obtained using the Hannover ECG System version 3.22-12 (HES, Corscience, Erlangen, Germany). ECGs were recorded after 10 min rest in supine position.

Electrocardiogram analysis was performed in parallel by two senior cardiologists blinded to BAC, chronic alcohol consumption levels, or clinical covariates. Discrepant findings were resolved by consent. Assessment of arrhythmias employed a standardized coding scheme. Arrhythmias were classified as sinus tachycardia (heart rate \>100 b.p.m.), sinus arrhythmia, premature atrial complex, premature ventricular complex, and atrial fibrillation or flutter. We further assessed all ECGs for respiratory sinus arrhythmia as a measure of autonomic tone. For this, we modified the previously described respiratory sinus arrhythmia bedside test.[@ehx156-B14] Per 30 s ECG recording, we measured RR intervals with a scaled caliper, neglecting RR intervals before and after premature beats, and determined the shortest, longest, and mean RR interval of each participant. We considered respiratory sinus arrhythmia present, when the absolute difference of the shortest and longest RR interval was ≥20% of the mean RR interval duration.

Alcohol assessment
------------------

In the acute alcohol cohort, BAC was determined using a Dräger Alcotest 7510 handheld device (Drägerwerk AG, Lübeck, Germany). The device accounts for remaining oral alcohol. To further reduce influence of the latter, BAC was obtained at the end of participant recruitment, when individuals had not ingested alcohol for several minutes. Alcohol was measured in gram per kilogram (g/kg). In KORA S4, chronic alcohol consumption was assessed in gram alcohol per day (g/d), surveyed using the validated 7-day-recall method.[@ehx156-B15]

Clinical covariates
-------------------

In our acute alcohol cohort, assessment of clinical covariates was restricted by the study setting and the aim to maintain participant privacy. We were thus limited to survey self-reported age, sex, country of origin, history of heart disease, use of cardiovascular and antiarrhythmic drugs, and active smoking status.

In KORA S4, participants underwent a standardized interview and examination.[@ehx156-B13] We used information on age, sex, hypertension, smoking status, history of angina, myocardial infarction, diabetes mellitus, and stroke, as well as the use of cardiovascular and antiarrhythmic medication.

Statistical considerations
--------------------------

We express categorical variables as frequency (percentage). Continuous data are presented as mean ± standard deviation or median (25th;75th percentile) as appropriate. We applied logistic regression models to assess the relation of alcohol as predictor on the primary and secondary outcomes of arrhythmia prevalence, adjusted for age and sex or in addition for the remaining available covariates. Odds ratios are provided per unit (i.e. 1 g/kg) increase of BAC. Arrhythmia prevalence across quartiles of BAC was compared by χ^2^ tests for trend. Primary outcome was the occurrence of any arrhythmia including sinus arrhythmia, sinus tachycardia, premature atrial complex, premature ventricular complex, and atrial fibrillation or flutter. Secondary outcomes were arrhythmia subtype separately or combinations thereof. Another secondary outcome in our acute alcohol cohort was the presence of respiratory sinus arrhythmia. For sensitivity analyses to adjudicate the influence of alcohol consumption on the baseline prevalence of sinus tachycardia, we selected a subgroup of participants from our acute alcohol cohort with no exposure to acute alcohol consumption (BAC 0 g/kg). Similarly, in KORA S4 we selected participants without chronic alcohol use. In these sensitivity analyses, we determined the prevalence of cardiac arrhythmias as detailed above. Finally, we assessed interaction with sex by adding multiplicative interaction terms (sex\*BAC) to our models.

For sample size calculations in the acute alcohol cohort, we assumed a 1% prevalence of arrhythmias in the general population assessed by a 10 s ECG. In our 30 s recordings, we assumed a 1.5% prevalence in those under no or low influence of alcohol (\<0.5 g/kg). For the group under intermediate (≥0.5--\<1.5 g/kg) and high (≥1.5 g/kg) influence, we assumed an odds of 2 and 4 for the prevalence of arrhythmias, respectively. For 85% power with a two-sided α-level set at 5%, we required 2754 participants. To account for a 10% drop-out rate, we aimed at 3029 enrolled individuals.

Results
=======

During all 16 days of the 2015 Munich Octoberfest we included 3028 participants for analysis. Their mean age was 34.7 ± 13.3 years, 905 (29.9%) were women (*Table [1](#ehx156-T1){ref-type="table"}*). Reflecting the international attendance, individuals originated from 60 different countries, whereas the majority of 69% was from Germany. Table 1Characteristics of the study cohortsAcute alcohol cohortChronic alcohol cohortMenWomenMenWomen*n*30282123905413120212110Sex (women), *n*(%)905 (29.9%)\--2110 (51.1%)\--Age, years34.7 ± 13.335.5 ± 13.433.1 ± 12.849.1 ± 13.949.5 ± 14.048.7 ± 13.8History ofHeart disease, *n*(%)175 (5.8%)140 (6.6%)35 (3.9%)\-\--Angina, *n*(%)\-\--249 (6.0%)116 (5.7%)133 (6.3%)Myocardial infarction, *n*(%)\-\--82 (2.0%)71 (3.5%)11 (0.5%)Diabetes mellitus, *n*(%)\-\--159 (3.8%)82 (4.1%)77 (3.6%)Stroke, *n*(%)\-\--49 (1.2%)33 (1.6%)16 (0.8%)Arrhythmias, *n*(%)80 (2.6%)57 (2.7%)23 (2.5%)\-\--Medication use, *n*(%)185 (6.1%)149 (7.0%)36 (4.0%)859 (20.8%)409 (20.2%)450 (21.3%)Current smoking, n(%)858 (28.3%)605 (28.5%)253 (28.0%)1066 (25.6%)616 (30.5%)450 (21.3%)

The KORA S4 cohort consisted of 4131 individuals with a mean age of 49.1 ± 13.9 years and 2110 (51.1%) females (*Table [1](#ehx156-T1){ref-type="table"}*). Owing to the study composition, \>99.5% were of German descent.

In the acute alcohol cohort, the mean BAC was 0.85 ± 0.54 g/kg (range 0--2.94 g/kg). Generally, men had a higher BAC compared to women. Across quartiles of age, the highest BAC was found in the 2nd quartile (25--30 years of age, *Figure [1](#ehx156-F1){ref-type="fig"}A*). We noted limited day-by-day variation, tending to higher BAC measurements towards the weekends (*Figure [1](#ehx156-F1){ref-type="fig"}C*). The circadian distribution confirmed a constant rise in BAC toward the closing hour of each day. A slight decline in the afternoon likely reflects a partial exchange of visitors due to seat reservation time slots (*Figure [1](#ehx156-F1){ref-type="fig"}D*).

![Alcohol consumption. *A.* Distribution of breath alcohol concentration (BAC) across the acute alcohol cohort in g/kg. Results presented for the entire cohort, and stratified by sex and quartiles of age. *B.* Distribution of chronic alcohol consumption in KORA S4 in g/d. Results presented for the entire cohort, and stratified by sex and quartiles of age. Outliers truncated at 80 g/d. *C.* Day-by-day variability of mean BAC for each of the 16 days of the Octoberfest. *D.* Circadian variability of mean BAC across recruitment days at the Octoberfest.](ehx156f1){#ehx156-F1}

The mean chronic consumption of alcohol in KORA S4 was 15.8 ± 21.4 g/d. On average, men consumed nearly three time as much alcohol as women. The highest chronic alcohol consumption was observed in the 3rd age quartile (37--48 years of age, *Figure [1](#ehx156-F1){ref-type="fig"}B*).

The quality of ECG recordings in our acute alcohol cohort was high, despite disadvantageous recording conditions. Only eight ECGs were uninterpretable. Examples of encountered arrhythmias are presented in *Figure [2](#ehx156-F2){ref-type="fig"}A*--*E*. In the acute alcohol cohort, the primary outcome of any arrhythmia occurred in 30.5%. Thereby, sinus tachycardia was most common and affected 25.9% of participants. The combined prevalence of other arrhythmias was 5.4%, including sinus arrhythmia, premature atrial and ventricular complexes, and atrial fibrillation or flutter. The secondary outcome of respiratory sinus arrhythmia as a qualitative measure of autonomic tone was noted in 22.2% of participants (*Table [2](#ehx156-T2){ref-type="table"}*).

![Examples and Prevalence of Cardiac Arrhythmias. *A--E*. Representative ECG recordings obtained in our acute alcohol cohort. ECG recordings show sinus rhythm (*A*), sinus tachycardia (*B*), premature atrial complex (*C*), premature ventricular complex (*D*), atrial fibrillation (*E*). *F--G.* Clustered bars represent the prevalence of the primary outcome of any cardiac arrhythmia (*F*) and sinus tachycardia (*G*) in our acute alcohol cohort by quartiles of BAC. Within each cluster, bars represent the overall cohort (green), and sex-stratified results for men (blue) and women (red). Clusters compared by χ^2^ test for trend.](ehx156f2){#ehx156-F2}

Table 2Prevalence of arrhythmiasAcute alcohol cohortChronic alcohol cohortMenWomenMenWomen1Sinus arrhythmia51 (1.7%)40 (1.9%)11 (1.2%)9 (0.2%)4 (0.2%)5 (0.2%)2Sinus tachycardia785 (25.9%)514 (24.2%)271 (29.9%)17 (0.4%)9 (0.4%)8 (0.4%)3Premature atrial complexes39 (1.3%)30 (1.4%)9 (1.0%)26 (0.6%)11 (0.7%)11 (0.5%)4Premature ventricular complexes52 (1.7%)39 (1.8%)13 (1.4%)46 (1.1%)19 (0.9%)27 (1.3%)5Atrial fibrillation/flutter25 (0.8%)12 (0.6%)13 (1.4%)22 (0.5%)18 (0.9%)4 (0.2%)Combination of 1, 2, 3, 4, 5925 (30.5%)614 (28.9%)311 (34.4%)112 (2.7%)58 (2.9%)54 (2.6%)Combination of 1, 3, 4, 5164 (5.4%)118 (5.6%)46 (5.1%)95 (2.3%)50 (2.2%)45 (2.1%)Combination of 3, 4, 5113 (3.7%)78 (3.7%)35 (3.9%)87 (2.1%)47 (2.0%)40 (1.9%)Respiratory sinus arrhythmia673 (22.2%)509 (24.0%)163 (18.0%)\-\--

In comparison, arrhythmias occurred less frequently in KORA S4. Only 2.7% of the participants met the primary outcome, at which 0.4% had sinus tachycardia and 2.3% presented with sinus arrhythmia, premature atrial and ventricular complexes, and atrial fibrillation or flutter (*Table [2](#ehx156-T2){ref-type="table"}*).

In our sensitivity analysis of study participants with 0 g/kg BAC in the acute alcohol cohort, the primary outcome of any arrhythmia occurred in 23.9%, and sinus tachycardia occurred in 18.5%. In those without alcohol use in the chronic alcohol cohort, prevalence of any arrhythmia was 2.5% and of sinus tachycardia was 0.4%.

For our primary outcome (sinus tachycardia; sinus arrhythmia; premature atrial and ventricular complexes; atrial fibrillation or flutter), we identified a robust association with higher BAC in our acute alcohol cohort. Analysis by arrhythmia subtype revealed that this association was driven by sinus tachycardia, both after age and sex, and after multivariable adjustment. (*Table [3](#ehx156-T3){ref-type="table"}*) Across quartiles of BAC in the overall and sex-stratified cohort, we found increasing prevalences of any arrhythmia and sinus tachycardia, respectively (*Figure [2](#ehx156-F2){ref-type="fig"}F* and G). In sex-stratified analyses, the effect of BAC on sinus tachycardia was similar in males and females, both after adjustment for age (males: OR 2.12 (95% CI 1.75--2.58), *P* \< 0.001; females: OR 2.02 (95% CI 1.51--2.69), *P* \< 0.001) and after multivariable adjustment (males: OR 2.00 (95% CI 1.64--2.44), *P* \< 0.001; females: OR 1.89 (95% CI 1.40--2.55), *P* \< 0.001). We also noted a significant inverse association of respiratory sinus arrhythmia with BAC (*Table [3](#ehx156-T3){ref-type="table"}*). Interaction analyses did not suggest interaction between sex and BAC. Table 3Association of arrhythmia prevalence with alcohol consumptionAcute alcohol cohortChronic alcohol cohortAdjusted forMultivariableAdjusted forMultivariableAge and SexAdjustmentAge and SexAdjustmentOR (95%CI)*P*OR (95%CI)*P*OR (95%CI)*P*OR (95%CI)*P*1Sinus arrhythmia0.74 (0.43--1.30)0.30.77 (0.44--1.35)0.360.97 (0.92--1.03)0.310.97 (0.91--1.02)0.252Sinus tachycardia2.08 (1.77--2.45)**\<0.001**1.96 (1.66--2.31)**\<0.001**1.02 (1.01--1.04)**0.003**1.03 (1.01--1.05)**0.006**3Premature atrial complexes0.88 (0.46--1.70)0.710.93 (0.48--1.81)0.840.99 (0.96--1.01)0.310.99 (0.96--1.01)0.354Premature ventricular complexes1.11 (0.64--1.92)0.711.07 (0.62--1.86)0.810.99 (0.97--1.01)0.430.99 (0.98--1.01)0.455Atrial fibrillation/flutter1.45 (0.67--3.13)0.351.39 (0.64--3.00)0.831.00 (0.98--1.02)0.801.00 (0.98--1.02)0.84Combination of 3, 4, 51.03 (0.70--1.51)0.871.03 (0.70--1.51)0.890.99 (0.98--1.00)0.210.99 (0.98--1.01)0.27Combination of 1, 3, 4, 50.93 (0.68--1.27)0.640.93 (0.68--1.28)0.670.99 (0.98--1.00)0.150.99 (0.98--1.00)0.18Combination of 1, 2, 3, 4, 51.87 (1.60--2.18)**\<0.001**1.75 (1.50--2.05)**\<0.001**1.00 (0.99--1.01)0.941.00 (0.99--1.01)0.90Respiratory sinus arrhythmia0.52 (0.44--0.63)**\<0.001**0.54 (0.45--0.65)**\<0.001**--------[^2]

In KORA S4, we confirmed an association between sinus tachycardia and chronic alcohol consumption. Yet, the associated effect size was remarkably smaller than with acute alcohol consumption. No associations with chronic alcohol consumption were found for other arrhythmias or a combination of sinus tachycardia with other arrhythmia subtypes (*Table [3](#ehx156-T3){ref-type="table"}*).

Discussion
==========

In our observational, cross-sectional acute alcohol cohort, we have recruited over 3000 participants with quantitatively measured acute alcohol consumption. Each participant received a 30 s ECG for arrhythmia analysis. Our main finding was a significant association of sinus tachycardia with acute alcohol intake, occurring in 25.9% of individuals. We also confirmed this association with chronic alcohol consumption in the community-based cohort KORA study. In the acute alcohol cohort, respiratory sinus arrhythmia as a marker of balanced autonomic tone was more common in those exposed to less alcohol.

The Octoberfest is a traditional public festival in the city of Munich, Germany that is celebrated annually since 1810. It has gained strong international recognition and is renowned for serving Munich-brewed beer. Numerous visitors attend the festival primarily for the purpose of beer consumption. In 2015, 5.9 million visitors frequented the Octoberfest and consumed 7.5 million liters of beer. We thus considered the setting most suitable for conducting our acute alcohol study. We anticipated that by recruiting participants during all 16 days of the festival, we would be able to enrol a sufficient number of individuals presenting with a continuously distributed range of BAC. With an average BAC of 0.85 g/kg (range: 0--2.94 g/kg) we clearly achieved this goal. The modest day-by-day and circadian variabilities of BAC support the robustness of our results. The lively atmosphere in a beer tent deviated from AliveCor manufacturer recommendations for ECG recording. Despite adverse recording conditions, with \>99.5% interpretable readings the obtained ECG quality was very high.

We conservatively based sample size considerations on an estimated 1.5% prevalence of any arrhythmia under no acute influence of alcohol and at rest. Even without considering sinus tachycardia, we detected arrhythmias in 2.3% of our chronic and in 5.4% of our acute alcohol cohorts. We thus submit that we present sufficiently powered results. In our acute alcohol cohort, we found a strong and robust association of increased BAC with sinus tachycardia in particular. We were not able to associate increased BAC with other arrhythmia subtypes and specifically atrial fibrillation. This is despite prior reports that repeatedly suggested such a relation coining the term 'holiday heart syndrome'.[@ehx156-B8] It is notable that so far studies have considered patients presenting with atrial fibrillation and have then retrospectively identified recent acute alcohol consumption as a presumed cause.[@ehx156-B8] Ours is the first large and prospective investigation to systematically analyse the immediate occurrence of arrhythmias under the influence of acute alcohol intake. We thus conclude that acute alcohol consumption leads to increased arrhythmia prevalence overall, with sinus tachycardia as the immediate main effect.

For chronic alcohol consumption, prior results are more equivocal. Based on large community-based studies, modest use does not appear to be a major risk factor for atrial fibrillation.[@ehx156-B16] Only long-term use in the Framingham Heart Study and beyond moderate use (\>35 standard drinks per week) in the Copenhagen City Heart Study resulted in an increased risk for atrial fibrillation.[@ehx156-B12]^,^[@ehx156-B17] Along these findings, in our own community-based analysis of low to moderate chronic alcohol consumption with less than 20 g/d on average, we did not find an association with an increased arrhythmia prevalence.

A main result of our study is the profound association of acute alcohol consumption with sinus tachycardia. As demonstrated in our sensitivity analysis, it is intuitive to assume that participants of a festival present with significantly higher rates of sinus tachycardia than under resting conditions. However, sinus tachycardia occurred almost 30% more often in Octoberfest participants under the influence of alcohol compared with those without alcohol consumption. Furthermore, the association of sinus tachycardia with higher BAC remained even after accounting for confounders. Although less pronounced, also in KORA S4 increased chronic alcohol consumption was associated with sinus tachycardia.

Whereas ours is the largest prospective analysis to describe the association of acute alcohol consumption and sinus tachycardia under real life conditions, the relation has previously been noted. Prior studies have reported an increase in heart rate following alcohol intake in experimental settings.[@ehx156-B18] Consistently, these studies have identified alcohol induced alterations of the autonomic nervous system to elevate heart rate. Thereby, both an increase in sympathetic activity[@ehx156-B18]^,^[@ehx156-B21] and a decrease in vagal tone[@ehx156-B19]^,^[@ehx156-B20] have been described. Respiratory sinus arrhythmia is a simple measure of cardiac vagal tone and autonomic balance.[@ehx156-B22] In our acute alcohol cohort, participants with increased BAC presented with a significantly reduced prevalence of respiratory sinus arrhythmia. This finding concurs with the interpretation that the observed alcohol induced increase in heart rate is the consequence of changes in autonomic balance. Autonomic imbalance is strongly predisposing to the development of atrial fibrillation.[@ehx156-B23]^,^[@ehx156-B24] Alcohol induced autonomic imbalance could thus hypothetically be a link to the later development of atrial fibrillation. Possibly, the short duration of our ECG recordings immediately during acute alcohol exposition resulted in an underestimation of alcohol induced cardiac arrhythmias and atrial fibrillation in particular. These considerations ask for additional research including longer ECG recordings during follow-up of hours and days after acute alcohol consumption.

A number of considerations are warranted when interpreting our study. Given the public environment of our study, we were restricted in assessing personal questions and conducting physical examinations. Hence, several possible confounding factors remained unaddressed, including but not limited to the amount of alcohol consumption prior to BAC measurement, the participants' common alcohol consumption behaviour, their use of recreational drugs, or their usual physical activity. A single 30 s ECG recording prevented the investigation of temporal relations between alcohol consumption and arrhythmia occurrence. Importantly, we cannot comment on the relevance of baseline heart rate prior to alcohol intake. We were thus only able to assess the prevalence but not the incidence of arrhythmias during follow-up. Future studies with longer ECG recordings will need to fill this gap. Respiratory sinus arrhythmia only partially reflects the influence of autonomic tone on heart rate variability. Additional research is warranted to investigate more elaborate measures of autonomic tone in relation to alcohol consumption. Due to our exclusion criteria, we were not able to study severely intoxicated individuals (BAC ≥3.00 g/kg). In KORA S4, chronic alcohol consumption was rather low compared with other community-based cohorts. We might thus have underestimated arrhythmia prevalence secondary to long-term alcohol use. Information on chronic alcohol consumption in our acute alcohol cohort was unavailable.

In conclusion, we have conducted a large prospective analysis of acute alcohol consumption on ECG-assessed cardiac arrhythmias. We thereby report good technical feasibility of ECG screening even under lively conditions at the Munich Octoberfest. Acute and---to a lesser extent---chronic alcohol consumption were associated with sinus tachycardia. Analysis of respiratory sinus arrhythmia as a measure of autonomic tone suggested that acute alcohol intake confers autonomic imbalance. Additional research is warranted to investigate if autonomic imbalance constitutes the link between sinus tachycardia and the occurrence of arrhythmias like atrial fibrillation, as implicated by reports of the so-called 'Holiday Heart Syndrome' (*Figure*[*3*](#ehx156-F3){ref-type="fig"}).

![MunichBREW study conclusions. The figure summarizes the study procedures and results in the panel shaded in green. These findings influence the generated hypothesis on 'Holiday Heart Syndrome' pathophysiology illustrated in the panel shaded in red. Importantly, additional research is warranted to support this hypothesis.](ehx156f3){#ehx156-F3}
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[^1]: See page 2107 for the editorial comment on this article (doi: 10.1093/eurheartj/ehx280)

[^2]: Odds ratios (OR) are presented per unit (i.e. 1 g/kg) increase of continuously measured breath alcohol concentration. Multivariable adjustment in the acute alcohol cohort included age, sex, history of heart disease, use of cardiovascular drugs, use of antiarrhythmic drugs, and active smoking status. Multivariable adjustment in the chronic alcohol cohort included age, sex, hypertension, smoking status, history of angina, myocardial infarction, diabetes mellitus, stroke, and use of cardiovascular and antiarrhythmic medication. Significant *P*-values are highlighted by bold print.
